Literature DB >> 21536654

Characterization of basigin isoforms and the inhibitory function of basigin-3 in human hepatocellular carcinoma proliferation and invasion.

Cheng-Gong Liao1, Ling-Min Kong, Fei Song, Jin-Liang Xing, Long-Xin Wang, Zhi-Jian Sun, Hao Tang, Hui Yao, Yang Zhang, Li Wang, Yu Wang, Xiang-Min Yang, Yu Li, Zhi-Nan Chen.   

Abstract

Basigin, which has four isoforms, plays an important role in invasion of hepatocellular carcinoma (HCC). Detailed transcriptional regulation and functions of the basigin isoforms have not been reported except in the case of the predominant isoform basigin-2, which act as inducer of matrix metalloproteinases (MMPs). Here we determined that basigin-2, basigin-3, and basigin-4 were the most abundant transcript variants in human cell lines. GeneRacer PCR and luciferase reporter assays showed that basigin-3 and basigin-4 were initiated from an alternative promoter. Basigin-3 and basigin-4 were widely expressed in various normal human tissues at the mRNA level and were upregulated in HCC tissues compared to in normal tissues. Western blotting and confocal imaging showed that glycosylated basigin-3 and basigin-4 were expressed and localized to the plasma membrane. However, in cultured cell lines, only native basigin-3, and not basigin-4, was detected at protein level. Overexpression of basigin-3 inhibited HCC cell proliferation, MMP induction, and cell invasion in vitro and in vivo. Bimolecular fluorescence complementation assays and nuclear magnetic resonance (NMR) analysis indicated that basigin-3 interacted with basigin-2 to form hetero-oligomers. In conclusion, we systematically investigated the alternative splicing of basigin and found that basigin-3 could inhibit HCC proliferation and invasion, probably through interaction with basigin-2 as an endogenous inhibitor via hetero-oligomerization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21536654      PMCID: PMC3133368          DOI: 10.1128/MCB.05160-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression.

Authors:  P Kirk; M C Wilson; C Heddle; M H Brown; A N Barclay; A P Halestrap
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

2.  A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation.

Authors:  Jing Xu; Zhong-Yang Shen; Xin-Guo Chen; Qing Zhang; Hui-Jie Bian; Ping Zhu; Hui-Yun Xu; Fei Song; Xiang-Min Yang; Li Mi; Qing-Chuan Zhao; Rong Tian; Qiang Feng; Si-He Zhang; Yu Li; Jian-Li Jiang; Ling Li; Xiao-Ling Yu; Zheng Zhang; Zhi-Nan Chen
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

3.  Characterization of the promoter of human extracellular matrix metalloproteinase inducer (EMMPRIN).

Authors:  Liang Liang; Terry Major; Thomas Bocan
Journal:  Gene       Date:  2002-01-09       Impact factor: 3.688

4.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

5.  Fine tuning of rabbit equilibrative nucleoside transporter activity by an alternatively spliced variant.

Authors:  Sharon K Wu; David K Ann; Kwang-Jin Kim; Vincent H L Lee
Journal:  J Drug Target       Date:  2005 Sep-Nov       Impact factor: 5.121

6.  Homo-oligomer formation by basigin, an immunoglobulin superfamily member, via its N-terminal immunoglobulin domain.

Authors:  S Yoshida; M Shibata; S Yamamoto; M Hagihara; N Asai; M Takahashi; S Mizutani; T Muramatsu; K Kadomatsu
Journal:  Eur J Biochem       Date:  2000-07

7.  A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis.

Authors:  T Igakura; K Kadomatsu; T Kaname; H Muramatsu; Q W Fan; T Miyauchi; Y Toyama; N Kuno; S Yuasa; M Takahashi; T Senda; O Taguchi; K Yamamura; K Arimura; T Muramatsu
Journal:  Dev Biol       Date:  1998-02-15       Impact factor: 3.582

8.  Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions.

Authors:  J Sun; M E Hemler
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

9.  HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma.

Authors:  Jing Xu; Hui-Yun Xu; Qing Zhang; Fei Song; Jian-Li Jiang; Xiang-Min Yang; Li Mi; Ning Wen; Rong Tian; Li Wang; Hui Yao; Qiang Feng; Yang Zhang; Jin-Liang Xing; Ping Zhu; Zhi-Nan Chen
Journal:  Mol Cancer Res       Date:  2007-06       Impact factor: 5.852

10.  Complementary methods for studies of protein interactions in living cells.

Authors:  Tom K Kerppola
Journal:  Nat Methods       Date:  2006-12       Impact factor: 28.547

View more
  39 in total

1.  HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.

Authors:  Ling Li; Wenhua Tang; Xiaoqing Wu; David Karnak; Xiaojie Meng; Rachel Thompson; Xinbao Hao; Yongmin Li; Xiaotan T Qiao; Jiayuh Lin; James Fuchs; Diane M Simeone; Zhi-Nan Chen; Theodore S Lawrence; Liang Xu
Journal:  Clin Cancer Res       Date:  2013-10-16       Impact factor: 12.531

2.  Regulation of invadopodia formation and activity by CD147.

Authors:  G Daniel Grass; Momka Bratoeva; Bryan P Toole
Journal:  J Cell Sci       Date:  2012-02-01       Impact factor: 5.285

Review 3.  Influence of transcriptional variants on metastasis.

Authors:  Joice De Faria Poloni; Diego Bonatto
Journal:  RNA Biol       Date:  2018-07-24       Impact factor: 4.652

4.  CD147 expression in peritoneal injury.

Authors:  Harald Seeger; Joerg Latus; Daniel Kitterer; M Dominik Alscher; Dagmar Biegger; Jin Chen; Ilka Edenhofer; Rudolf P Wüthrich; Stephan Segerer
Journal:  Clin Exp Nephrol       Date:  2017-05-27       Impact factor: 2.801

Review 5.  RNA splicing: a dual-edged sword for hepatocellular carcinoma.

Authors:  Anjali Kashyap; Greesham Tripathi; Avantika Tripathi; Rashmi Rao; Manju Kashyap; Anjali Bhat; Deepak Kumar; Anjali Rajhans; Pravindra Kumar; Darshan Shimoga Chandrashekar; Riaz Mahmood; Amjad Husain; Hatem Zayed; Alok Chandra Bharti; Manoj Kumar Kashyap
Journal:  Med Oncol       Date:  2022-08-16       Impact factor: 3.738

6.  The phosphorylation of CD147 by Fyn plays a critical role for melanoma cells growth and metastasis.

Authors:  Xu Zhang; Zunnan Huang; Yeye Guo; Ta Xiao; Ling Tang; Shuang Zhao; Lisha Wu; Juan Su; Weiqi Zeng; Hongbin Huang; Zheng Li; Juan Tao; Jianda Zhou; Xiang Chen; Cong Peng
Journal:  Oncogene       Date:  2020-04-14       Impact factor: 9.867

7.  miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1.

Authors:  Mei-Mei Guo; Li-Hua Hu; Yong-Qiang Wang; Peng Chen; Jian-Guo Huang; Ning Lu; Jiang-Hong He; Cheng-Gong Liao
Journal:  Med Oncol       Date:  2013-03-26       Impact factor: 3.064

8.  Tumor-derived microvesicles mediate human breast cancer invasion through differentially glycosylated EMMPRIN.

Authors:  Kerstin Menck; Christian Scharf; Annalen Bleckmann; Lydia Dyck; Ulrike Rost; Dirk Wenzel; Vishnu M Dhople; Laila Siam; Tobias Pukrop; Claudia Binder; Florian Klemm
Journal:  J Mol Cell Biol       Date:  2014-12-11       Impact factor: 6.216

9.  Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancer.

Authors:  Shu-Hua Zhao; Yu Wang; Li Wen; Zhen-Bo Zhai; Zhen-Hua Ai; Nian-Ling Yao; Li Wang; Wen-Chao Liu; Bi-Liang Chen; Yu Li; Hong Yang
Journal:  J Transl Med       Date:  2013-04-08       Impact factor: 5.531

10.  Overexpression of EMMPRIN isoform 2 is associated with head and neck cancer metastasis.

Authors:  Zhiquan Huang; Ning Tan; Weijie Guo; Lili Wang; Haigang Li; Tianyu Zhang; Xiaojia Liu; Qin Xu; Jinsong Li; Zhongmin Guo
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.